about
Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.Airway pressure release ventilation during ex vivo lung perfusion attenuates injury.Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor AntagonismMechanisms of lung ischemia-reperfusion injury.NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion InjuryEx vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion.Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysmsAdenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation modelNatural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury.Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation.Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.Enhanced fibrinolysis protects against lung ischemia-reperfusion injuryNADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationAlveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury.Muscle-derived extracellular superoxide dismutase inhibits endothelial activation and protects against multiple organ dysfunction syndrome in mice.In vivo lung perfusion rehabilitates sepsis-induced lung injury.Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.Adenosine 2A Receptor Activation Attenuates Ischemia Reperfusion Injury During Extracorporeal Cardiopulmonary Resuscitation.Expanding the donor lung pool: how many donations after circulatory death organs are we missing?Protecting Donor Livers During Normothermic Machine Perfusion With Stem Cell EVs.Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.Pannexin-1 channels on endothelial cells mediate vascular inflammation during lung ischemia-reperfusion injury
P50
Q30252567-35A128B3-FFF9-424E-884B-5BFE0128CC0DQ30275729-D699A93A-C072-4E50-B3E6-D80CF65486BAQ30275958-4AD6318C-E515-45DC-99DB-25D170C9F517Q30276921-17B0940B-1445-47AA-9ADE-FB3DF3290D1AQ30277205-694B3C1A-DB4F-418F-B86F-30A18596C306Q30277768-68DD184A-099F-4A4A-8D52-4D08DCA5B528Q30278780-BB26F2DE-CEE7-44B7-BEF5-EAC63D3D0671Q30278868-B7C63D68-01FB-4A57-8C3D-4F64F480102FQ30300119-9736177D-18FB-4B03-9D13-5F385682B898Q30408739-0FC2A240-152A-4204-BBF9-B77B93C80678Q30412759-A4141E19-8D72-4C19-A1BE-672F9A71F9F5Q30412838-4A320DDD-4ABD-4053-9BBE-D86B6A4AB5A8Q30413271-A8835672-5A7A-409A-B0AC-E5F1CBC601F0Q30416644-48EB91BC-D435-457F-B984-FF94027F8FADQ30417206-EA4B3137-BB2D-4286-AD5F-B2B352F893DCQ30422075-9A9D7EFD-14AE-4E59-AFBA-4B2D77D78036Q30424759-A67837B7-AC52-44FF-8481-B16B0F5F15FBQ30426574-09FE7FEA-E858-4B51-B7E3-C6117C5AD28FQ30427036-12A6FD7F-D95F-4685-B0BD-958EA70AA4B3Q30430492-0342F9D6-EA3C-4D41-B768-6A8797BE78D4Q30431134-FD619DAE-ABAF-4DB0-A128-2203995993CEQ30433358-0AAA3F08-953E-4519-AEDB-D56D711C94B5Q30436290-2B39E711-6A21-451F-B0B6-C0F1F55F3A12Q30436865-1056AC62-7705-46D1-8255-64581911281AQ30436951-C590D3B2-4CD6-4EA2-B2D5-9BE7D887350CQ30438077-9BFDEEA4-882F-4E8A-896C-DF1C7D1DE7E4Q30439172-951912C6-CFAE-4393-9152-C1B1FB7ED46CQ30441084-82AA2ECB-127C-4DB6-94E1-5C8918897892Q30443389-C0CA8E3F-2327-4CE5-9C90-698E03B02A25Q41990697-B58B5CB3-2C61-43B8-8F88-6C184E0C6F71Q45070121-48B44FD0-2FF9-4274-8F76-F742E6603A7EQ47124715-04C885B8-A431-4293-A447-E1D523BCD6DEQ49657585-3F8EDECD-B963-4C84-8D73-72025B87D422Q50046316-96214F19-BF20-49A0-816A-CEA7DC715E4FQ50183533-6C69F73B-F7C7-4361-94A2-47F2187F5DA6Q54118155-F3E51D29-EE1B-45BD-9DC2-94A596AB881AQ56334587-2CE62F34-477A-4A92-B891-54FA2C196BC0
P50
name
Ashish K Sharma
@ast
Ashish K Sharma
@en
Ashish K Sharma
@nl
type
label
Ashish K Sharma
@ast
Ashish K Sharma
@en
Ashish K Sharma
@nl
prefLabel
Ashish K Sharma
@ast
Ashish K Sharma
@en
Ashish K Sharma
@nl